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ABSTRACT
Macaluso, F, Morici, G, Catanese, P, Ardizzone, NM, Marino
Gammazza, A, Bonsignore, G, Giudice, GL, Stampone, T,
Barone, R, Farina, F, and Di Felice, V. Effect of conjugated
linoleic acid on testosterone levels in vitro and in vivo after an
acute bout of resistance exercise. J Strength Cond Res 26(6):
1667–1674, 2012—The purposes of the present study were
to investigate the effect of conjugated linoleic acid (CLA)
supplementation on testosterone levels in vitro on a cell line
derived from Leydig cells (R2C) and in vivo in the blood
of physically active subjects before and after a resistance
exercise bout. In vitro R2C cells were treated with different
CLA concentrations (0–30 mM) for 24 and 48 hours. After
treatment, supernatant media were tested to determine
testosterone secretion. The CLA increased the testosterone
secretion only after 48 hours. In vivo, 10 resistance-trained male
subjects, in a double-blind placebo-controlled and crossover
study design were randomized for 3 weeks of either 6 gd21
CLA or placebo. Blood was drawn pre and post each
resistance exercise bout to determine the total testosterone
and sex hormone–binding globulin (SHBG) levels. No signif-
icant differences were observed for total testosterone or SHBG
pre and post each resistance exercise bout; although after
the resistance exercise bouts, total testosterone increased
moderately (effect size = moderate), whereas after CLA
supplementation, there was a large increase in total testoster-
one (effect size = large). CLA supplementation induced an
increase in testosterone levels in Leydig cells in vitro after
48 hours but not in vivo before and after a resistance exercise
bout. These findings suggest that CLA supplementation may
promote testosterone synthesis through a molecular pathway
that should be investigated in the future, although this effect
did not have an anabolic relevance in our in vivo model.




onjugated linoleic acid (CLA) is a group of
positional and geometric isomers of linoleic acid
(cis-9, cis-12-octadecadienoic acid), an omega-6
essential fatty acid. The characteristic features of
these isomers are that, unlike linoleic acid, the 2 double bonds
along the 18-carbon fatty acid chain are separated by a single
carbon-carbon bond, not a methylene group. The 2 main
isomers of CLA are cis-9, trans-11 and trans-10,cis-12
octadecaenoic acids (c9,t11-CLA, t10,c12-CLA) (16).
The use of CLA supplements is spreading among elite and
recreational athletes because marketing claims suggest that
it can improve endurance capacity, increase _VO2max, reduce
body mass, reduce muscle glycogen breakdown, improve
metabolism, prevent or reduce muscle damage and the
inflammatory response, promote fat loss, and reduce
catabolism (15,18). Although only a few studies have been
conducted to evaluate the effects of CLA supplementation
and exercise training (endurance and resistance) in animal
and human subjects. In animals, it has been demonstrated
that CLA supplementation combined with endurance
training augments the positive effect of training, that is,
decreases body weight (11) and adipose tissue (1,11) and
increases lean body mass (1), muscle hypertrophy (7), and
endurance performance (19). Although the results in animals
show that CLA supplementation has positive effects, the
studies conducted with humans show contradictory results.
Kreider et al. (18) and Pinkoski et al. (21), who investigated
the effects of CLA supplementation during resistance
exercise training on subjects performing different sporting
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activities, observed different results despite the fact that both
performed randomized controlled studies. Conjugated linoleic
acid supplementation in experienced resistance-trained athletes
did not induce differences in total body mass, body com-
position, and strength (18), whereas in moderately physically
active subjects, CLA induced a relatively small increase in lean
body mass and a decrease in body fat mass (21).
The effect of CLA supplementation on body fat mass
reduction has been investigated (5), and in in vitro studies, the
lipolytic effect of CLA on adipocytes seems to be mediated
by an increase in the levels of a protein named perilipin A (6).
The proteins of the perilipin family are found not only on the
outer surface of lipid storage droplets of adipocytes (linked to
the hormone-sensitive lipase) but also in steroidogenic cells,
such as Leydig cells in testicles, associated to the cholesteryl
esterase (22). The steroidogenic cells’ cholesteryl esters, pre-
cursors of testosterone, are stored in the intracellular lipid
droplets of Leydig cells (22). Moreover, it has previously
been suggested that exercise training might alter the amount
and the function of perilipin (20).
Considering the lipolytic effect of CLA, the role of perilipins
in the pathway leading to steroid hormone synthesis and the
effect of exercise on perilipin function, it was hypothesized that
CLA supplementationmaymediate an increase in testosterone
secretion. The purposes of the study were (a) to investigate the
effect of CLA supplementation on testosterone synthesis in
Leydig cells, an in vitromodel for studying steroid biosynthesis,
and (b) to test the effect of CLA supplementation on testos-
terone levels in vivo in the blood of physical active subjects and
after a resistance exercise bout. We suppose that the results
from this study will lead the practitioners to understand if the
CLA supplementation can be useful to increase the testoster-
one synthesis immediately after an acute session of resistance
exercise affecting the anabolic phase followed by each strength
training session.
METHODS
Experimental Approach to the Problem
To test if CLA supplementation has an effect on the synthesis
of testosterone, we approached the problem using in vitro and
in vivo models.
Subjects
For the first model, we used a Leydig cell line, which is
steroidogenic without cAMP stimulation (22). Investigation of
the effect of CLA on a rat cell line was done because (a) it is
unethical to perform a testicular biopsy in humans without any
prior results from animal studies that justify them; (b) it is
impossible to obtain a 100% pure Leydig cell culture from
animal testes, and these cells are hard to maintain in culture,
unlike the cell line used; and (c) only the R2C cell at a basal
conditioning level produces steroid hormones, simulating
the activation of these cells in humans after a resistance exercise
bout, while Leydig cells isolated from animal testis require the
addition of human chorionic gonadotropin to produce steroid
hormones. The cells were treated with different concentration
of CLA, and the supernatant medium was tested after 24 and
48 hours to determine total testosterone synthesis.
The human model was conducted as a crossover, double-
blind, placebo-controlled clinical trial. All subjects gave the
investigators informed consent before participating in the
study. Subjects were assigned to condition using randomiza-
tion and provided with CLA or placebo for 3 weeks. After 2
weeks of washout, the groups were switched and all subjects
received the opposite substance for an additional 3 weeks.
Before and after each supplementation period, the subjects
underwent a resistance exercise bout and body composition
analysis. Blood samples were collected for hormone analyses
before and after each resistance exercise bout.
The concentration of CLA supplementation administered
for the in vivo experiment was based on doses previously used
in literature and not on the doses used in the in vitro
experiment because it is unethical to perform a testicular
biopsy to verify actual CLA concentration of the testis. The
study was conducted in Sicily (Italy) during springtime.
A: In Vitro
Cell Cultures. Rat Leydig Cells (R2C, cat. No. 89031606,
ECACC; Health Protection Agency Culture Collections, Salis-
bury, United Kingdom)were cultured in 75-cm2 flasks in M-199
medium (Invitrogen Corp., Carlsbad, CA, USA) supplemented
with 15% horse serum (Invitrogen Corp), 2.5% fetal bovine
serum (Invitrogen Corp), and antibiotic antimycotic solution
(penicillin 100 Uml21, streptomycin 100 mgml21, amphoter-
icin B 0.25 mgml21; Invitrogen Corp). Cells were incubated at
37C in a humidified atmosphere with 5% CO2 and fed 3 times
a week until reaching 80 to 90% confluence. Adherent cells
were harvested with trypsin in Ca2+- and Mg2+-free Hanks’
balanced salt solution (Invitrogen Corp), washed with phos-
phate-buffered saline and resuspended in the supplemented
M-199 medium.
Conjugated Linoleic Acid Treatment. When cells reached about
80% confluence, they were treated with the CLA working
solution at increasing concentrations (0–30 mM, to reduce the
error of the operator, we used dilution series 1:2 starting from the
30 mMconcentration) for 24 and 48 hours. To prepare the CLA
working solution, the Tonalin FFA 80 (Cognis Nutrition and
Health) was first dissolved in absolute ethanol and then in
fetal bovine serum containing 1% bovine serum albumin
(Sigma–Aldrich, St. Louis, MO, USA).
Viability Test. The CLA working solution concentrations used
were testedwith a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-
thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay (MTS
test). For the MTS assay, the CellTiter 96 Aqueous One
Solution Cell Proliferation Assay kit (Promega Corporation,
Madison, WI, USA) was used following the manufacturer’s
instruction. Briefly, cells were seeded at 5 3 103 cells per well
in 96-well plates, and after the incubation period of 24 and
48 hours with the CLA working solution, 20 mL of the MTS
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reagent was added to eachwell and cells were incubated at 37C
for 3 hours. At the end of the incubation period, the absorbance
of the formazan produced was detected at 490 nm with
a multiwell plate reader (DV990BV4; GDV, Rome, Italy). CLA
induced cell death at concentrations higher than 15 mM after
48 hours (30–40% of mortality). Hence, to study the synthesis
of testosterone in vitro, we used concentrations up to 7.5 mM.
The MTS test was performed in quintuplicate.
Testosterone Analysis. Cells were seeded at 5 3 104 cells per
well in 24-well plates. To determine testosterone secretion,
the medium was collected at the end of the incubation period
and subsequently analyzed with an Immulite 2000 (Medical
System S.P.A., Genova, Italy). Total testosterone analysis in
cell culture was performed in triplicate in 5 different
independent experiments.
B: In Vivo
Subjects. Ten physically active male subjects (age, 27.4 6 3.7
years; height, 176.7 6 5.2 cm; weight, 81.1 6 9.8 kg; body
mass index (BMI), 25.96 2.6 kgm22; body fat, 15.1 6 3.1%)
volunteered to participate in this investigation. Subjects were
informed of the experimental procedures and associated risk
before providing written informed consent. This study
conformed to the standards set by the latest revision of the
Declaration of Helsinki, and it was approved by the
institutional review board for the protection of human
subjects of the University of Palermo. Each subject had more
than 2 years of resistance training experience and had been
training at least 3 times per week over the last year. All
subjects completed a health history questionnaire, were
healthy, and had no medical contraindications or history of
any endocrine disorders. The subjects were not vegetarians,
nor did they follow a carbohydrate-restricted diet. No
subjects were taking any medications or nutritional supple-
ments, and all were nonsteroid users and nonsmokers.
Baseline hormones and sex hormone–binding globulin
(SHBG) blood levels are summarized in Table 1.
Experimental Design. This study was conducted as a crossover,
double-blind, placebo-controlled, clinical trial. The subjects
were randomized to groups receiving either CLA (see below
for dosage) or placebo (PLA) for 3 weeks. After 2 weeks of
washout, the groups were switched and all subjects received
the opposite substance for an additional 3 weeks. Before and
after each supplementation period, the subjects underwent
body composition analysis and a resistance exercise bout.
During the 6 weeks (3 weeks 3 2 times) of supplementation,
the subjects were instructed to consume their regular diet
(carbohydrate, 57.56 5.0%; lipid, 15.06 2.5%; protein, 25.56
1.5%), to maintain their usual training routine (resistance
training 3 times per week, 60 6 7.5 minutes per training
session), and tomaintain normal nocturnal sleep habits (86 1
hour per night). No differences were observed during the
study period in macronutrients ingested, training hours per
session, and nocturnal sleep hours per night (analysis
performed on diet, training, and sleep questionnaires filled
out daily by the subjects). It was recommended that they
abstain from vigorous exercise, alcohol use, and sexual activity
for at least 24 hours before the resistance exercise bout. All the
subjects declared to abstain from these activities 24 hours
before the resistance exercise bout.
Conjugated Linoleic Acid and PLA Supplementation.The subjects
ingested 7 opaque soft gel capsules of CLA (6 g of Tonalin
FFA 80; Cognis Group, Monheim, Germany) or PLA (6 g of
sunflower oil) per day, both identical in taste and in appearance.
TheCLAand placebo dosageswere used in literature in studies
that investigated the effect of CLA supplementation on body
mass composition (18,21); moreover, this CLA dose is
suggested by the food supplement manufacturers. The CLA
supplement was a mixture containing 40% c9,t11-CLA and
40% t10,c12-CLA. The rest of the mixture was made of other
fatty acids (10% of oleic acid, ,4% of palmitic acid, ,4% of
stearic acid, and ,3% of linoleic acid). At the beginning of
each supplementation period, the subjects received 3 boxes
with 56 pills each. At the end of each supplementation period,
the remaining pills per box were counted to verify the
supplement intake. Subjects consumed 99.6 6 1.3% and
99.26 1.7% of the prescribed intake during the CLA and PLA
supplementation periods, respectively.
1 Repetition Maximum Strength Test. Maximal strength was
determined for each of the 8 exercises of the resistance
protocol (leg press, leg curl, leg extension, lat pull-down,
bench press, shoulder press, barbell bicep curl, and supine
triceps extension). This was
assessed by completing a 1
repetition maximum (1-RM)
strength test (i.e., the heaviest
load that can be lifted one time
through a full range of motion).
Three to 4 subsequent attempts
were performed to determine
the 1-RM strength, with the
weight increasing progressively
until the subjects failed at the
given load. The 1-RM strength
test was preceded by awarm-up
TABLE 1. Baseline value of hormones and SHBG blood level.*†
Baseline CI (90%) Normal range
Total testosterone, ngdL21 429.4 6 113.6 370.3–488.5 290–1,300
Cortisol, mgdL21 8.9 6 2.3 7.7–10.1 5–25
Estradiol, pgmL21 24.2 6 12.5 17.7–30.7 14–55
SHBG, nmolL21 26.8 6 9.0 22.1–31.5 20–60
*CI, confidential intervals; SHBG, sex hormone–binding globulin.
†All values are means 6 SD.
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session consisting of 10-minute cycling on a stationary bike,
5-minute light stretching, and 2 to 3 sets of 8 to 10 repetitions
of leg press at ,50% of perceived maximal strength.
1 Repetition maximum strength tests were performed 1
week before the start of each resistance bout protocol.
Resistance Exercise Bout Protocol. The resistance exercise bout
consisted of 8 resistance exercises. The subject’s goal was to
complete 3 sets of 8 to 10 repetitions at approximately 75% of
that subject’s 1-RM strength. One minute of rest between
each set and 2 minutes between each exercise were allowed
for recovery. The number of repetitions and the amount of
weight lifted in each exercise were recorded to calculate the
total lifting volume, that is, the training volume.
A warm-up was performed before each resistance exercise
bout. This resistance exercise protocol was based on Bird et al.
(3) and was chosen because (a) it involves a large muscle
mass at high intensity simulating training of recreational
gymnasium users, differently from other protocols proposed
in literature, and (b) it increases (around 30%) the total
testosterone concentration in men until the end of the
resistance exercise bout. The resistance exercise bouts and
the 1-RM strength test were performed under the supervision
of qualified personal trainers.
Body Composition Analysis. Body composition analysis was
performed early in the morning after a night of fasting on the
first and the last day of each supplementation period with the
Inbody 320 (BioSpace, Seoul, Korea), a bioelectrical imped-
ance analyzer. The device uses 8 points of tactile electrodes
(contact at the hands and feet) and 3 frequencies (5, 50, and
200 kHz) to measure body mass (kilograms), body fat mass
(kilograms), lean body mass (kilograms) and intra- and
extracellular water (14). All subjects were asked to empty
their bladders immediately before the measurements. The
bioelectrical impedance analysis was performed with subjects
dressed only in their underwear (with all jewelery removed).
The validity and reliability of this specific bioelectrical
impedance analyzer in adult men has been reported by
Jensky-Squires et al. (14).
Blood Sampling and Analysis. Each resistance exercise bout
was performed at 4:00 PM after a 4-hour fast, to minimize the
influence of diurnal variations on exercise performance
and hormonal response (2). Blood was drawn before (pre)
and after (post) each resistance exercise bout from the
antecubital vein to determine hormone concentrations
(total testosterone, estradiol, and cortisol) and SHBG levels.
Subjects sat quietly for 15 minutes, after which a butterfly
needle was inserted into the antecubital forearm vein and
the pre blood samples were drawn. The subjects remained
sitting quietly for another 15 minutes, to minimize hor-
monal fluctuations related to anticipatory responses. The
post blood samples were drawn 5 minutes after completion
of the resistance exercise bout (2). The tubes were gently
inverted 5 times and allowed to stand at room temperature
for a minimum of 20 minutes. Samples were then
centrifuged for 10 minutes at 3,000 revolutions per minute,
with the supernatant removed, placed into plastic storage
containers, and frozen at 280C until analysis. Percentage
changes in plasma and red cell volume were calculated
using hemoglobin and hematocrit concentrations, according
to Dill and Costill (8). Blood measurements were performed
by the hematology laboratory of ‘‘Azienda Ospedaliera Villa
Sofia–CTO Palermo.’’ The hormones and SHBG were
measured on an Immulite 2000 (Siemens, Milan, Italy) using
the manufacturer’s instruction, fully described previously (10).
Briefly, the automated instrument dropped a single assay--
specific bead into a sample tube that was agitated at 37C.
After the sample tube was agitated at 37C, then washed and
a chemiluminescent substrate added. The amount of light
generated was measured by the photomultiplier tube, and
the quantity of hormone was calculated by the software of
the instrument. Inter- and intra-assay coefficients of variances
were 9.5 and 8.3% for total testosterone (Immunolite 2000
testosterone total), 9.0 and 6.2% for estradiol (Diasorin
estradiol, Liaison estradiol, DiaSorin, Stillwater, MN, USA),
7.0 and 5.5% for cortisol (Immunolite 2000 cortisol), and 4.2
and 3.0% for SHBG (Immunolite 2000 SHBG).
Statistical Analyses
One-way analysis of variance (ANOVA) for different CLA
concentrations was performed on testosterone secretion by
R2C cells. Pearson’s correlation was performed for testoster-
one synthesis in vitro. Body composition measurements
and mean training volumes were analyzed by 2-way
ANOVA for repeated measures: supplementation (CLA
and PLA) vs. training (before and after). Hormones and
SHBGmeasurements were analyzed by 3-way ANOVAwith
repeatedmeasures: supplementation vs. training vs. resistance
exercise bout (pre and post). Cohen’s effect size (ES) was also
calculated to determine the effect of supplementation on
testosterone level (ES# 0.2, small; 0.2, ES# 0.6, moderate;
ES . 0.6, large). Assumptions for ANOVA were assessed,
and ANOVAs were robust to violation of normality and
homogeneity. If a significant difference was detected during
1-, 2- or 3-way ANOVAs, this was further evaluated by post
hoc Tukey’s test. Confidence intervals (90%) for baseline
values and normal ranges of hormones and SHBG blood
level are summarized in Table 1. Statistical analyses were
performed using Statistica (StatSoft, Inc, Tulsa, OK, USA).
All data are presented as means 6 SEM, and the level of
statistical significance was set at p # 0.05.
RESULTS
Testosterone Production In Vitro
In the R2C cells, the CLA working solution induced an
increase in the concentration of the secreted testosterone
within 48 hours (Figure 1). Testosterone secretion increased
linearly with CLA supplementation (R2 = 0.520, p , 0.018).
This effect was not evident at 24-hour treatment.
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Serum Hormones and Sex
Hormone–Binding Globulin
The serum hormones and
SHBG concentration results
are shown in Figure 2. There
was a significant interaction of
the resistance exercise bout on
total testosterone (p , 0.05)
and cortisol levels (p , 0.05).
The total testosterone and
cortisol concentration in-
creased significantly at the
end of the exercise bouts,
although the post hoc analysis
did not indicate any significant
difference between pre and
post resistance exercise bouts.
After the resistance exercise
bouts, total testosterone in-
creased moderately (ES =
moderate), whereas after
CLA supplementation, there
was a large increase in total
testosterone (ES = large). The
Figure 2. Serum hormones and SHBG. All values are means 6 SEM. *Moderate ES between pre and post. †Large ES. Before, at the beginning of
supplementation; after, at the end of supplementation; CLA, conjugated linoleic acid supplementation; ES, effect size; PLA, placebo supplementation; post, post
resistance exercise bout; pre, pre resistance exercise bout; SHBG, sex hormone–binding globulin.
Figure 1. Testosterone production in R2C cells at 24 hours (:) and 48 hours (n) at different CLA concentrations.
All values are means 6 SEM. CLA concentrations used: 0, 0.03, 0.06, 0.12, 0.24, 0.48, 0.95, 1.90, 3.75, and
7.5 mM. The dotted line indicates a linear trend line for testosterone synthesis at 24 and 48 hours. †Significantly
different than 0, 0.03, and 0.06 mM. CLA, conjugated linoleic acid.
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large ES in total testosterone level after CLA supplemen-
tation was not induced by a fluid shift because there was no
difference in plasma and red cell volume among the 4
resistance exercise bouts. The estradiol and SHBG plasma
levels did not change in relation to supplementation,
training, or resistance exercise bouts.
Training Volume
No significant differences were observed among the trials in
sum or with each exercise lifting volume (Table 2).
Body Composition
The absolute data on body composition are shown in Figure 3.
There were no significant differences in total body mass, body
fat mass, and lean body mass before and after the CLA and
PLA supplementation. No difference was observed in intra-
and extracellular water (data not shown).
DISCUSSION
The possible positive effect of CLA supplementation on the
body composition of sedentary or physically active subjects
has been previously reported (5); however, our study is the
first that provides a set of laboratory data in vitro and in vivo
and may yield some insight into the possible mechanisms
induced by exercise training and CLA in the modulation of
testosterone levels in the blood. Considering the lipolytic
effect of the CLA that is mediated by an increase in the level
of the perilipin A protein and taking into account the role of
perilipins in the pathways lead-
ing to steroid hormone synthe-
sis, we investigated the effect of
this supplementation on the
levels of testosterone in vitro
in a cell line derived from
Leydig cells and in vivo in the
blood of physically active sub-
jects after a bout of resistance
exercise. The results of this
study will help practitioners
and coaches to understand if
the CLA supplementation can
be useful to increase the testos-
terone synthesis immediately
after an acute session of
resistance exercise affecting
the anabolic phase followed
by each strength training ses-
sion. It has previously been
suggested that the acute eleva-
tion of testosterone could me-
diate an anabolic phase after
each strength training session,
TABLE 2. Training volume.*†
Before PLA After PLA Before CLA After CLA
Leg press, kg 4,031 6 1,233 4,253 6 1,128 3,912 6 1,179 4,193 6 1,547
Leg curl, kg 926 6 215 1,023 6 284 927 6 210 942 6 239
Leg extension, kg 1,203 6 317 1,307 6 353 1,382 6 622 1,373 6 675
Lat pull-down, kg 2,033 6 450 1,988 6 478 1,959 6 554 2,161 6 354
Bench press, kg 2,296 6 559 2,126 6 631 2,222 6 557 23,11 6 542
Shoulder press, kg 1,646 6 741 1,830 6 787 1,551 6 670 1,659 6 423
Barbell bicep curl, kg 952 6 217 1,003 6 202 943 6 203 951 6 209
Supine triceps extension, kg 939 6 274 1,051 6 447 1,015 6 420 1,046 6 431
Total volume, kg 13,637 6 3,223 14,222 6 3,318 14,306 6 3,671 15,170 6 3,851
*CLA, conjugated linoleic acid supplementation; PLA, placebo supplementation.
†All values are means 6 SD.
Figure 3. Body composition. All values are means 6 SEM. After, at the end of supplementation; Before, at the
beginning of supplementation; CLA, conjugated linoleic acid supplementation; PLA, placebo supplementation. SEs
are indicated with error bars, above for total body mass and below for lean body mass and body fat mass.
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when the muscle is exposed to the anabolic hormone only for
a short period (13).
Conjugated linoleic acid induced an increase in testosterone
production in our in vitro experiments. This increase in
testosterone production after 48 hours of treatment is
proportional to the increase in CLA concentration. The
mechanism by which CLA may induce an increase in
testosterone level is not known. In normal Leydig cells,
testosterone production is dependent on cholesteryl esterase
activation by cAMP (22) and lipid hydrolysis depends on
dislocation of phosphorylated perilipin A/C proteins from the
membrane of the lipid droplet (4). The role of perilipin in
testosterone synthesis is poorly understood, but it should
represent only one of the complex steps of the testosterone
synthesis pathway. Considering that the cAMP signaling
pathway is inhibited in these cells (22) and also that
testosterone is increased after CLA treatment, we can
postulate that CLA may induce the activation of perilipin
proteins in a cAMP independent manner; therefore, we
hypothesize that CLA may have an effect on the steps by
which cholesteryl esterase leads to testosterone synthesis in
the cytoplasm.
In light of this rise in testosterone synthesis after CLA
treatment, we decided to investigate whether CLA supple-
mentation may directly influence testosterone blood levels
before and after a resistance exercise bout in humans. The
human model was conducted using a resistance exercise bout
protocol previously used in literature (3) to increase total
testosterone in men. In our study, an overall significant
increase in total testosterone and cortisol levels was observed
after the resistance exercise, although no difference was seen
between interventions. The testosterone and the cortisol
results seem to suggest that the resistance exercise program
was not markedly stressful for our subjects (i.e., young
healthy physically active men). In fact, to induce an acute
testosterone response, an acute resistance exercise program
needs to contain higher volume and higher metabolic
demand in relation of the sex and the age of the subjects
tested (23). In humans, the blood level of total testosterone
after CLA supplementation after the resistance exercise bouts
did not increase significantly as in vitro, although the ES
analysis showed a large increase in total testosterone level
after CLA supplementation and a moderate increase after
placebo supplementation. Conjugated linoleic acid supple-
mentation did not affect the estradiol, cortisol, and SHBG
blood levels either before or after a resistance exercise bout.
The data obtained in in vivo do not support our in vitro
results but, although there was not a significant increase in
testosterone synthesis induced by CLA supplementation, our
data showed that after a resistance exercise bout and CLA
supplementation, there was a potential slightly higher acute
elevation of total testosterone. Furthermore, 2 potential
limitations of the in vivo study need to be taken into
consideration. The in vitro experiments are indicative of
a direct effect of CLAon testosterone synthesis, but we do not
know the amount of CLA that accumulates in the testis
interstitium and what the active doses on Leydig cells in vivo
are. To perform our in vivo experiments, we used doses
previously used in literature to test CLA on body mass
composition and suggested by the CLA food supplement
manufacturers, and it is clear that different doses and dosages
need to be tested to understand the effect of CLA on
testosterone synthesis in vivo. Another potential limitation in
the lack of an effect of CLA on testosterone in vivo could be
because of the insufficient exercise stimuli induced by the
chosen resistance exercise program in our participants.
Studies conducted in animals have shown that CLA is
effective in reducing body fatmass, increasing insulin sensitivity,
and decreasing plasma glucose levels (12). These results have
led to an increased interest as to whether CLAwould have the
same effects in humans. The studies that investigate the effect of
CLA supplementation in people who are overweight indicate
that CLA helps to reduce body fat mass without affecting BMI
and body weight (9). The effects of CLA supplementation on
the body composition of trained subjects, as reported in the
literature, are controversial. Pinkoski et al. (21) observed
a relatively small increase of lean body mass and a decrease of
body fat mass in 76 moderately physically active subjects fed
with CLA for 7 weeks, whereas Kreider et al. (18) showed that
4 weeks of CLA supplementation had no effects on the body
composition of 23 bodybuilders. The 3 weeks of CLA
supplementation did not induce significant changes in total
body weight and body composition in our subject. Our results
support the data of Kreider et al. (18), showing that CLA
supplementation for a short period (3–4 weeks) combined with
exercise does not affect body weight and composition.
In conclusion, our results in vitro demonstrated that CLA
supplementation may induce an increase in the testosterone
levels, whereas, from the in vivo experiment, it is difficult to
generalize that CLA supplementation does not affect
testosterone synthesis. As acute hormonal responses show
the type and the level of stress affecting the homeostasis of
a specific population (17), we can conclude that in young
healthy physical active men, CLA supplementation does not
significantly increase testosterone synthesis after an unmark-
edly stressful bout of acute resistance exercise. Additional
research on the effect of CLA on perilipins in the pathway
leading testosterone synthesis is important to elucidate the
possible mechanism by which CLA can help resistance
athletes or people who are overweight.
PRACTICAL APPLICATIONS
The results of the present study show that CLA may have an
effect on testosterone synthesis, although only a potentially
slight increase in total testosterone compared with the
placebo was observed in physically active men. It means that
CLA might be used as an ergogenic aid to increase the
anabolic effect of a resistance exercise bout, but further
research is needed to understand the physiological relevance
of this slight effect on testosterone.
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